infertility
Conditions
Interventions
Experimental group:In vitro fertilization-embryo transfer assisted pregnancy using the COS protocol suggested by the FSH drug delivery platform
Control group:Conventional IVF-Embryo Transfer Assisted Pregnancy
Sponsors
The Affiliated Reproductive Hospital of China Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. The woman aged 20-40 years; 2. Clinical treatment requires in vitro fertilization-embryo transfer (IVF/ICSI-ET) assisted pregnancy; 3. AMH>=1.2ng/ml, AFC>=10; 4. Voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Physical examination patients with contraindications for assisted reproduction, such as liver and kidney dysfunction, autoimmune diseases, acute phase of infectious diseases, untreated endocrine diseases, severe endometriosis and large ovarian cysts ; 2. Abnormal karyotype analysis, suffering from family genetic diseases, etc.; 3. Patients with azoospermia on the male side; 4. Patients who are participating in other clinical trials; 5. The researchers believe that they are not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of eggs retrieved;Ovarian hyperstimulation syndrome incidence;Elimination of embryo transfer rates to avoid ovarian hyperstimulation;FORT value;Total follicle stimulating hormone dose;Follicle stimulating hormone starting dose;Ovulation induction days;Fresh-cycle embryo transfer rates;The high quality embryo rate;The proportion of 10-15 oocyte cycles; | — |
Secondary
| Measure | Time frame |
|---|---|
| HCG day serum estradiol level;The fertilization rate;The clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactSui Yang
The Affiliated Reproductive Hospital of China Medical University
Outcome results
None listed